In the CTD-PAH subgroup, the magnitude of the relationship between serum endostatin and mortality was attenuated, and its significance was lost (HR 1.76, 95% CI 0.94–3.32, p=0.08). The gene discussed is COL18A1; the disease is pulmonary arterial hypertension.